Molbio Diagnostics Limited (NSE: MOLBIO), ISIN INE869T01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MOLBIO last traded at ₹1216.50 (+1.62%), with a 52-week range of ₹925.80 to ₹1234.20 (as of 25 Aug 2026).
Shareholding as of Jun 2026: promoters 41.29%, FIIs 1.51%, DIIs 16.37%, mutual funds 2.25%.
Data sourced from NSE and BSE filings. Educational — not investment advice.